Health Care

The drugmakers plan to fight a federal verdict ordering them to pay $9 billion after a jury ruled they failed to disclose Actos cancer risks.

MannKind said the FDA extended the review date of its inhaled insulin treatment by three months so that it has more time to review the data submitted by the drug company and the FDA's third-party committee. 

Shares of Halozyme slumped more than 23% Friday after the company halted a trial for its experimental pancreatic drug amid concerns from a third-party review committee. 

Shares of MannKind skyrocketed 80% after health regulators recommended almost unanimously that its diabetes drug Afrezza be granted approval.

Shares of Intuitive Surgical jumped 14% after the device maker said its next-generation non-invasive surgical system was approved for marketing in the U.S. 

Eli Lilly forecast a decline in earnings, in line with views, hurt by cheaper generic forms of its Zyprexa and Cymbalta drugs.

Attention consumers who need health coverage by Jan.1, just  singing up for coverage on a state or federal exchange doesn’t mean you have coverage.

The insurer expects a delay in the enrollment period for the state-based health exchanges after the rocky start to this marketplace.

AstraZeneca appointed former GlaxoSmithKline executive Marc Dunoyer as chief financial officer on Thursday and revealed an 18% decline in third-quarter profit.

Employers continue to grapple with the ObamaCare’s implementation and its various requirements, with companies like UPS voicing more concern over the cost of complying with the new health law.

As the Affordable Care Act’s rocky rollout continues, hundreds of thousands of individuals nationwide are receiving notices from their insurers that their current policies are being terminated.

 The Affordable Care Act’s second week of open enrollment continued on its bumpy path, but the state-run exchanges are moving to the head of the class.

Those looking to avoid penalties under the individual mandate portion of the Affordable Care Act reportedly have to sign up for coverage by Feb. 14, 2014, six weeks before the exchanges’ open enrollment period ends.

When it comes to just how many people signed up for health care insurance on the exchanges last week, the administration is remaining mum. Here’s a look at the latest comments, and why it may be too soon to ask for enrollment numbers.

McAfee warned the launch of health-care exchanges will likely inspire phishing attacks aimed at stealing personal information.

The U.S. hospital operator has reportedly received buyout interest from Community Health Systems and others.

In a 5-3 vote, the Supreme Court ruled the Federal Trade Commission can challenge deals brand-name drug companies make with generic rivals that keep cheaper products off the market.

Food regulators are looking into the potential impact of Wrigley's new Alert Energy Caffeine Gum on children and adolescents. 

The shipping giant agreed to forfeit $40 million in payments received from doing business with illicit online pharmacies.

The U.S. Securities and Exchange Commission is investigating allegations that Andrew Liveris, chairman and chief executive officer of industrial giant Dow Chemical, misused company funds for personal benefit, according to people familiar with the matter.